Global Fish-Oil Based Drugs Market to reach USD XX billion by 2027.Global Fish-Oil Based Drugs Market is valued approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2021-2027. Fish oil is obtained from many types of fish and plants also. It is rich in omega-3 fatty acids. It is widely used in drugs in various kinds of medical conditions like mental health including anxiety and depression. Growing prevalence of coronary heart disease and rising neuro-degenerative diseases are key drivers for the growth of Fish-Oil Based Drugs market. According to Alzheimer Disease International's (ADI)- 2019 world Alzheimer report around 0.05 billion people in the world are affected by dementia, and by 2050 this number will triple to 0.152 billion. Also, with the increasing demand from pharmaceutical industry, the adoption & demand for Fish-Oil Based Drugs is likely to increase the market growth during the forecast period. However, high cost of Fish-Oil Based Drugs and its side effects impedes the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global Fish-Oil Based Drugs market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing research and development activities, surging consumption of improved medication in the region. Whereas Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2021-2027. Factors such rising disposable income and growing healthcare sector in the region would create lucrative growth prospects for the Fish-Oil Based Drugs market across Asia-Pacific region.

Major market player included in this report are:
Aker Bio marine Antarctic AS

Orkla Health

BASF SE

Omega Protein Corp.

GC Reiber Oils

Lonza

Croda International Plc

EPAX

BioProcess Algae, LLC

Koninklijke DSM N.V.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Docosahexaenoic acid
Eicosapentaenoic acid
Alpha-Linolenic acid
Others
By Source:
Marine Source
Plant Source

By Application:
Supplements and functional foods,
Pharmaceuticals,
Infants Formula,
Animal Feed & Pet Food,
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Fish-Oil Based Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors